Posted in FDA, bipolar, drug makers, drug updates, wellbutrinXL, tagged wellbutrin, FDA probe clears generic wellbutrin, generic wellbutrin, teva's generic wellbutrin XL, glaxosmithkline, budeprion XL on April 17, 2008 | No Comments »
from fiercepharma:
5. FDA probe clears generic Wellbutrin
Comment | Forward to a friend
Listen to all those generics makers heaving sighs of relief. The FDA has given the thumbs-up to Teva’s generic Wellbutrin XL, which has been under investigation since early last year. Patients who’d switched from GlaxoSmithKline’s branded form of 300 mg pill to Teva’s Budeprion [...]
Read Full Post »
Posted in FDA, big pharma, consumers' rights, drug makers, drug updates, tagged FDA, drug makers, big pharma, pfizer reuling, vioxx, bayer's baycol, FDA reviewers, approved drugs, drug safety on March 27, 2008 | No Comments »
i don’t think i need to comment about this one! is it any surprise that understaffed FDA approvals that are rushed to meet the deadline are more likely to be unsafe when they reach the public?
from fiercepharma newsletter:
When FDA reviewers cram, do they perform poorly on the test? A new study concludes that yes, when [...]
Read Full Post »
this is from “the financial times” via the newsletter from “fiercebiotech”. it is just interesting to read this article comming from the FDA to pharma execs…politics and pricing have nothing to do with difficulties…the fault lies with science? do you believe that?
“Pharma is having a difficult time but we are seeing drugs that have a [...]
Read Full Post »
taking away the right to sue drug companies…big pharma must be leaning back, laughing and holding its fat belly!
from the washington independant 3/24/08:
“But throughout the history of the Food and Drug Administration, and its precursor agencies, U.S. consumers could always bring the manufacturer of a faulty product to court. Now, with the FDA woefully underfunded [...]
Read Full Post »
